CLYM Shares Outstanding History — Climb Bio Share Count Over Time

As of 7/31/2026 Climb Bio has 57.44 million CLYM shares outstanding. Investors often track the CLYM shares outstanding history to compare shareholder return trends against the change in share count over time.

This page shows CLYM share count trends over time, with 8 historical shares outstanding datapoints presented, dating back to 8/12/2024.

Quick links: Shares Outstanding History Table  |  Shares Outstanding History Chart  |  About Climb Bio
CLYM Shares Outstanding History



Below is a table of the CLYM shares outstanding history going back to 8/12/2024:

Date CLYM Shares Outstanding
8/12/202467.06M
11/7/202467.22M
3/21/202567.48M
7/31/202567.76M
10/31/202568.18M
2/27/202647.77M
4/30/202657.26M
7/31/202657.44M

Also see: CLYM Market Cap History
CLYM YTD Return
CLYM Historical Shares Outstanding:
-7.57% CAGR
CLYM Historical Shares Outstanding: +-7.57% CAGR

Mouse over chart for data details
8/12/2024 ...7/31/2026
Climb Bio, Inc., formerly Eliem Therapeutics, Inc., is a clinical-stage biotechnology company. Co. is focused on developing therapeutics for patients with immune-mediated diseases. Co.'s lead product candidate, budoprutug, is an anti-CD19 monoclonal antibody designed to deplete CD19-positive B cells, including antibody-secreting cells, in order to directly reduce pathogenic autoantibodies. The reduction of autoantibodies has the potential to be disease-modifying in autoantibody-driven diseases, such as systemic lupus erythematosus, immune thrombocytopenia, and membranous nephropathy. The budoprutug is in Phase I clinical trial. We show 8 historical shares outstanding datapoints in our coverage of CLYM's shares outstanding history.

Understanding the changing numbers of CLYM shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like CLYM versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching CLYM by allowing them to research CLYM shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree CLYM Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance
Climb Bio (CLYM) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

CMAX Shares Outstanding History
CMD Shares Outstanding History
CMPI Shares Outstanding History
CMPX Shares Outstanding History
CMRA Shares Outstanding History
CMRX Shares Outstanding History
CNAT Shares Outstanding History
CNC Shares Outstanding History
CNCE Shares Outstanding History
CNMD Shares Outstanding History
More Healthcare companies »
 

CLYM Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?
⤹


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.